Main Content start here
Main Layout
Report Description

Report Description

Forecast Period

2026-2030

Market Size (2024)

USD 1.48 Billion

Market Size (2030)

USD 2.19 Billion

CAGR (2025-2030)

6.72%

Fastest Growing Segment

Integration & Interoperability

Largest Market

Mid-West

Market Overview

The United States Blood Management System Market was valued at USD 1.48 Billion in 2024 and is expected to reach USD 2.19 Billion by 2030 with a CAGR of 6.72%. The United States Blood Management System Market is experiencing robust growth, propelled by the increasing demand for efficient blood utilization and the integration of advanced technologies. The rising prevalence of chronic diseases, such as cancer and anemia, along with a growing number of surgical procedures, necessitates effective blood management solutions. Healthcare institutions are adopting sophisticated blood management systems to optimize blood usage, reduce wastage, and ensure patient safety. Furthermore, the aging population contributes to the heightened need for blood products, reinforcing the importance of streamlined blood management practices. The emphasis on patient blood management (PBM) programs, which focus on minimizing unnecessary transfusions and enhancing patient outcomes, is also a significant driver in the market's expansion.

Technological advancements are reshaping the landscape of blood management systems in the United States. The integration of artificial intelligence (AI) and machine learning algorithms enables predictive analytics for blood demand forecasting, inventory management, and donor recruitment strategies. Cloud-based platforms facilitate real-time data access and interoperability among healthcare providers, enhancing coordination and decision-making processes. Mobile applications and digital platforms are being leveraged to engage donors, schedule appointments, and provide educational resources, thereby improving donor retention rates. Moreover, the development of automated blood processing devices and consumables enhances the efficiency and safety of blood collection, testing, and storage procedures. These technological innovations are instrumental in addressing the complexities of blood management and ensuring a reliable blood supply chain.

Despite the positive trajectory, the United States Blood Management System Market faces several challenges. One significant hurdle is the persistent shortage of blood donors, which is exacerbated by demographic shifts and changing lifestyles. The limited shelf life of blood products, particularly platelets and red blood cells, poses logistical challenges in maintaining adequate inventory levels. Additionally, the high costs associated with implementing and maintaining advanced blood management systems can be a barrier for smaller healthcare facilities. Regulatory compliance and data security concerns also necessitate stringent measures to protect patient information and ensure adherence to standards. Addressing these challenges requires collaborative efforts among stakeholders, including government agencies, healthcare providers, and technology developers, to foster innovation, enhance donor engagement, and streamline blood management processes.

Key Market Drivers

Growing Demand for Blood and Blood Products

The growing demand for blood and blood products is expected to bolster the growth of the United States Blood Management System Market in the coming years. Various medical conditions, including surgeries, cancer treatments, and organ transplants, necessitate blood transfusions to improve patient outcomes. This growing need for blood transfusions directly drives the demand for advanced blood management systems. In 2021, the American Red Cross stated that sickle cell disease affected about 1,00,000 people in the United State. These patients require blood transfusion throughout their lives, therefore increasing the demand for blood transfusions. The growing demand for blood and blood products is surging with the adoption of blood management systems, as healthcare facilities recognize the need for efficient management of blood inventory, tracking, and transfusion processes to meet the rising demand. As a result, the demand for blood management systems is surging, thereby driving the growth of the United States Blood Management System Market.

Rising Surgical Volume and Trauma Cases

The rising surgical volume and trauma cases are significant drivers for the growth of the United States Blood Management System Market. In the United States alone, over 51 million inpatient surgical procedures were performed in 2022. These procedures often require substantial blood transfusions, highlighting the need for efficient blood management systems to ensure timely availability and reduce complications. The increasing number of trauma cases, including those from accidents, natural disasters, and violence, has amplified the demand for prompt and effective blood management solutions in hospitals and emergency settings. For instance, in 2022, unintentional injuries led to 227,039 deaths in the U.S. Efficient management of blood during surgeries and trauma care is crucial for improving patient outcomes and reducing complications. Blood loss during surgeries can lead to severe conditions like hypovolemic shock and anemia, necessitating the need for precise blood management. This surge in surgical and trauma cases underscores the importance of real-time monitoring, blood tracking, and optimal storage to ensure the availability and safety of blood products.

Blood management systems are critical for enhancing the safety and efficiency of transfusions, preventing adverse reactions, and managing blood resources effectively. To address these needs, medical institutions and healthcare providers are adopting advanced blood management systems that incorporate features such as real-time temperature monitoring, automated tracking, and secure storage. These systems help maintain blood quality and reduce wastage, ensuring that the right blood product is available when needed. The growth of surgical volumes and trauma cases directly influences the demand for more sophisticated and reliable blood management systems to ensure patient safety and improve clinical outcomes.

Growing Awareness among Healthcare Professionals and the Public

Growing awareness among healthcare professionals and the public about the importance of blood management is another factor influencing the United States Blood Management System Market. Healthcare professionals, including physicians, nurses, and laboratory staff, are increasingly recognizing the significance of proper blood management practices. They are becoming more aware of the potential risks associated with unnecessary blood transfusions, such as infections, transfusion reactions, and resource wastage. This awareness drives the adoption of blood management systems that help healthcare professionals make informed decisions, optimize blood utilization, and improve patient outcomes.

Also, with a greater focus on patient safety and quality of care, healthcare professionals are realizing the importance of implementing standardized blood management protocols. Blood management systems provide tools and guidelines that enhance patient safety by ensuring appropriate blood product utilization, reducing the risk of transfusion-related complications, and improving overall healthcare outcomes. Furthermore, the increasing awareness of healthcare costs has prompted healthcare professionals to explore strategies for cost containment. Blood management systems help optimize blood product utilization, reduce unnecessary transfusions, and minimize wastage. By implementing these systems, healthcare facilities can achieve cost savings while ensuring adequate supply for patients in need, which in turn, is expected to strengthen the growth of the United States Blood Management System Market.

In addition, the public's growing awareness of healthcare-related issues extends to the understanding of blood transfusions and their potential risks and benefits. Patients are more likely to be proactive in discussing their treatment options with healthcare providers and seeking alternatives to blood transfusions when appropriate. This growing patient awareness and empowerment are driving healthcare facilities to adopt blood management systems that support patient-centered care and provide alternatives to transfusions, such as intraoperative cell salvage or minimally invasive procedures. There are various programs and initiatives that promote the use of blood management systems such as National Blood Transfusion Council (NBTC) Programs, International Foundation for Patient Blood Management (IFPBM), etc.


Download Free Sample Report

Key Market Challenges

High Implementation and Maintenance Costs

High implementation and maintenance costs present a significant challenge for the United States Blood Management System Market. The upfront costs involved in acquiring and setting up advanced blood management systems, which include purchasing software, hardware, and storage devices, can be substantial. Many hospitals and blood banks face budget constraints, making it difficult for them to invest in these comprehensive solutions. These systems often require substantial initial capital investment, which can be a barrier for smaller institutions or those in developing regions. The integration of these systems into existing infrastructure also requires extensive customization, which adds to the overall cost.

Maintenance of these systems further compounds the financial burden. Regular updates, software licenses, and technical support are required to ensure smooth operation and compliance with evolving regulatory standards. Additionally, advanced features such as real-time temperature monitoring, AI-driven analytics, and automated tracking systems require continuous calibration, which incurs additional costs. For instance, ensuring the reliability of cold storage units for blood products, along with the necessary infrastructure for data security and system monitoring, can be an expensive ongoing process.

For healthcare providers, the challenge lies in balancing the benefits of these advanced systems, such as improved patient outcomes and reduced wastage, against the ongoing costs. The financial strain can result in delays in adopting these technologies, especially in resource-limited settings. Furthermore, the lack of skilled personnel to operate and maintain these systems adds another layer of complexity. The high cost of implementation and maintenance remains a key hurdle in the widespread adoption of advanced blood management systems, especially in smaller healthcare facilities and emerging markets.

Data Privacy and Cybersecurity Concerns

​Data privacy and cybersecurity concerns present significant challenges for the United States Blood Management System Market. The increasing digitization of blood management systems has led to a surge in cyberattacks targeting healthcare organizations. For instance, in January 2025, the New York Blood Center experienced a ransomware attack that compromised its IT systems, disrupting operations and delaying blood deliveries to over 200 hospitals. Similarly, in July 2024, OneBlood, a nonprofit blood provider serving multiple U.S. states, reported a ransomware event affecting its software systems and disrupting blood delivery operations.​

These incidents underscore the vulnerability of blood management systems to cyber threats, which can lead to unauthorized access to sensitive donor and patient data, operational disruptions, and compromised patient safety. The U.S. Food and Drug Administration (FDA) has highlighted the importance of cybersecurity resilience in blood establishments, noting that recent cybersecurity incidents have disrupted healthcare systems and halted blood establishment operations. Such breaches not only jeopardize patient care but also erode public trust in blood donation programs.​

To mitigate these risks, blood management organizations must invest in robust cybersecurity measures, including encryption, multi-factor authentication, and regular system audits. Ensuring compliance with data protection regulations and adopting a proactive approach to cybersecurity are essential steps to safeguard sensitive information and maintain the integrity of blood management systems.

Key Market Trends

Adoption of Cloud-Based Blood Management Solutions

​The adoption of cloud-based blood management solutions is significantly transforming the United States Blood Management System Market. Cloud technology offers scalable and secure storage solutions for blood bank data, facilitating easier access and management. These systems enable remote monitoring and data sharing, enhancing collaboration among healthcare providers. By eliminating the need for extensive on-premises infrastructure, cloud-based solutions reduce operational costs and allow blood banks to focus more on patient care. This shift is particularly beneficial for smaller institutions and those in emerging markets, where resource constraints often limit the adoption of advanced technologies. ​

Moreover, cloud-based systems support integration with Electronic Health Records (EHR), enabling seamless data exchange between blood banks and healthcare providers. This integration ensures that the right blood is delivered to the right patient, improving transfusion safety and efficiency. The ability to access data remotely also enhances decision-making processes, allowing for timely interventions and better resource management. As healthcare systems continue to prioritize digital transformation, the adoption of cloud-based blood management solutions is expected to increase, driving improvements in blood supply chain management and patient outcomes.

Rise of Mobile and Remote Access Solutions

The integration of mobile and remote access solutions is transforming the United States Blood Management System Market, enhancing efficiency and accessibility in blood collection, storage, and transfusion processes. Mobile health (mHealth) technologies enable real-time monitoring and management of blood products, facilitating timely interventions and reducing wastage. These solutions are particularly beneficial in remote and underserved areas, where traditional infrastructure may be lacking. By leveraging mobile platforms, healthcare providers can track blood inventory, monitor storage conditions, and ensure compliance with safety standards from virtually any location. This mobility enhances responsiveness and supports decentralized healthcare delivery models.

This trend is mirrored in blood management systems, where mobile solutions are increasingly adopted to streamline operations and improve patient outcomes. The rise of mobile and remote access solutions in blood management is driven by advancements in mobile technology, increased demand for real-time data, and the need for more efficient and accessible healthcare services. As these technologies continue to evolve, they are expected to play a pivotal role in shaping the future of blood management systems, offering enhanced capabilities and broader reach in healthcare delivery.

Segmental Insights

Type Insights

Based on the Type, Donor Management Module emerged as the dominant segment in the United States Blood Management System Market in 2024. This is due to its critical role in streamlining donor-related activities and improving the efficiency of blood collection processes. This module plays a vital part in maintaining accurate donor records, managing appointment scheduling, tracking donation history, and ensuring compliance with eligibility criteria. The increasing emphasis on optimizing donor engagement and retention has led healthcare organizations and blood banks to invest in advanced donor management solutions that offer real-time data access, seamless integration with electronic health records (EHR), and enhanced communication tools. The demand for this module has also grown as regulatory frameworks become stricter regarding blood safety and traceability.

End User Insights

Based on the End User, Hospitals emerged as the dominant segment in the United States Blood Management System Market in 2024. This dominance is due to their central role in the demand, utilization, and management of blood and blood-related products. Hospitals are at the forefront of performing surgeries, trauma care, emergency procedures, transplants, and complex treatments that require continuous and precise blood inventory management. As a result, they rely heavily on integrated blood management systems to ensure timely availability, reduce wastage, monitor transfusion safety, and comply with stringent regulatory standards. These systems enable hospitals to automate workflows related to blood requisition, cross-matching, and transfusion monitoring, thus enhancing clinical outcomes and operational efficiency. The growing need for minimizing human errors in transfusion practices and maintaining accurate patient records has accelerated the adoption of advanced software solutions in hospital settings.


Download Free Sample Report

Regional Insights

The Mid-West region emerged as the dominant region in the United States Blood Management System Market in 2024. This is primarily due to its extensive network of well-established hospitals, academic medical centers, and regional blood centers. States like Illinois, Ohio, and Michigan have prioritized healthcare infrastructure development and digitization, fostering the widespread adoption of advanced blood management technologies. These states benefit from strong public-private collaborations that support innovation in healthcare IT systems, including electronic health records (EHRs) and transfusion tracking platforms. As a result, healthcare providers in the region are better equipped to manage blood inventories, ensure safety compliance, and streamline donor-to-patient workflows. The region’s large and aging population has also driven demand for surgical procedures, cancer treatments, and emergency care services, all of which require efficient blood utilization and management. Institutions across the Mid-West have embraced automation and real-time data analytics to improve transfusion outcomes and reduce wastage.

Recent Developments

  • In January 2025, Terumo Blood and Cell Technologies announced that Carter BloodCare became the first U.S. adopter of its Reveos Automated Blood Processing System and Lumia Software Platform. Carter BloodCare, a major Texas-based blood center, is now using Reveos to automate the separation of whole blood into red cells, plasma, and platelets. Reveos, already in use across 50+ countries, is the first U.S.-approved device to process whole blood into three components in a single centrifugation step. The system simplifies blood processing, improves efficiency, and enhances platelet yield addressing national platelet shortages and advancing operational capabilities in blood centers.
  • In December 2024, BD (Becton, Dickinson and Company) and Babson Diagnostics announced the expansion of their fingertip blood collection and testing technology across U.S. health systems and provider networks. The solution combines BD’s MiniDraw Capillary Blood Collection System with Babson’s BetterWay technology, enabling lab test results from just six drops of blood collected via fingerstick. Designed for use in urgent care, physician offices, and ambulatory settings, the system allows trained healthcare staff without phlebotomy experience to collect samples, offering a less-invasive alternative to traditional blood draws.
  • In July 2024, Delta Development Team, Inc. became the first company to introduce a complete prehospital blood management system. This innovation aims to transform emergency blood management by ensuring accountability during storage and transport, while enabling EMS providers to save more lives. Delta Development offers a comprehensive, technology-driven system that tracks and manages blood storage throughout the process. The system includes Phase Change Material (PCM) preparation, high-tech storage devices with real-time temperature monitoring, and intuitive software for remote management, ensuring compliance and accountability.
  • In August 2023, Terumo Blood and Cell Technologies received FDA clearance for its Reveos Automated Whole Blood System, the first of its kind in the U.S. The system automates the separation of platelets and other components in a single centrifugation cycle, streamlining blood processing. This innovation is expected to enhance efficiency in blood centers and improve platelet availability for patients.

Key Market Players

  • Cerner Corporation
  • Haemonetics Corporation
  • Telvent GIT S.A.
  • Terumo Corporation
  • Fresenius SE & Co. KGaA
  • Grifols, S.A.
  • Baxter International Inc.
  • Stryker Corporation
  • Becton, Dickinson and Company
  • Biolife Solutions, Inc.

By Type

By End User

By Region

  • Donor Management Module
  • Transfusion Service Module
  • Inventory Management
  • Donation Scheduling
  • Screening & Testing
  • Reporting & Analytics
  • Integration & Interoperability
  • Others
  • Blood Banks
  • Hospitals
  • Ambulatory Care Centers
  • Others
  • North-East
  • Mid-West
  • West
  • South

 

Report Scope:

In this report, the United States Blood Management System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • United States Blood Management System Market, By Type:

o   Donor Management Module

o   Transfusion Service Module

o   Inventory Management

o   Donation Scheduling

o   Screening & Testing

o   Reporting & Analytics

o   Integration & Interoperability

o   Others

  • United States Blood Management System Market, By End User:

o   Blood Banks

o   Hospitals

o   Ambulatory Care Centers

o   Others

  • United States Blood Management System Market, By Region:

o   North-East

o   Mid-West

o   West

o   South

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the United States Blood Management System Market.

Available Customizations:

United States Blood Management System Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

United States Blood Management System Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.           Markets Covered

1.2.2.           Years Considered for Study

1.2.3.           Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    United States Blood Management System Market Outlook

5.1.  Market Size & Forecast

5.1.1.           By Value

5.2.  Market Share & Forecast

5.2.1.           By Type (Donor Management Module, Transfusion Service Module, Inventory Management, Donation Scheduling, Screening & Testing, Reporting & Analytics, Integration & Interoperability, Others)

5.2.2.           By End User (Blood Banks, Hospitals, Ambulatory Care Centers, Others)

5.2.3.           By Region

5.2.4.           By Company (2024)

5.3.  Market Map

6.    North-East Blood Management System Market Outlook

6.1.  Market Size & Forecast

6.1.1.           By Value

6.2.  Market Share & Forecast

6.2.1.           By Type

6.2.2.           By End User

7.    Mid-West Blood Management System Market Outlook

7.1.  Market Size & Forecast

7.1.1.           By Value

7.2.  Market Share & Forecast

7.2.1.           By Type

7.2.2.           By End User

8.    West Blood Management System Market Outlook

8.1.  Market Size & Forecast

8.1.1.           By Value

8.2.  Market Share & Forecast

8.2.1.           By Type

8.2.2.           By End User

9.    South Blood Management System Market Outlook

9.1.  Market Size & Forecast

9.1.1.           By Value

9.2.  Market Share & Forecast

9.2.1.           By Type

9.2.2.           By End User

10.  Market Dynamics

10.1.   Drivers

10.2.   Challenges

11.  Market Trends & Developments

11.1.   Merger & Acquisition (If Any)

11.2.   Product Launches (If Any)

11.3.   Recent Developments

12.  Disruptions: Conflicts, Pandemics and Trade Barriers

13.  Policy & Regulatory Landscape

14.  United States Economic Profile

15.  United States Blood Management System Market: SWOT Analysis

16.  Porter’s Five Forces Analysis

16.1.   Competition in the Industry

16.2.   Potential of New Entrants

16.3.   Power of Suppliers

16.4.   Power of Customers

16.5.   Threat of Substitute Products

17.  Competitive Landscape

17.1.   Cerner Corporation

17.1.1.        Business Overview

17.1.2.        Company Snapshot

17.1.3.        Products & Services

17.1.4.        Financials (As Reported)

17.1.5.        Recent Developments

17.1.6.        Key Personnel Details

17.1.7.        SWOT Analysis

17.2.   Haemonetics Corporation

17.3.   Telvent GIT S.A.

17.4.   Terumo Corporation

17.5.   Fresenius SE & Co. KGaA

17.6.   Grifols, S.A.

17.7.   Baxter International Inc.

17.8.   Stryker Corporation

17.9.   Becton, Dickinson and Company

17.10. Biolife Solutions, Inc.

18.  Strategic Recommendations

19.  About Us & Disclaimer

Figures and Tables

Frequently asked questions

Frequently asked questions

The market size of the United States Blood Management System Market was estimated to be USD 1.48 Billion in 2024.

Cerner Corporation, Haemonetics Corporation, Telvent GIT S.A., Terumo Corporation, Fresenius SE & Co. KGaA, Grifols, S.A., Baxter International Inc., Stryker Corporation, Becton, Dickinson and Company, Biolife Solutions, Inc. were the top players operating in the United States Blood Management System Market in 2024.

Limited adoption of advanced blood management systems in emerging markets, high costs of implementing blood management technologies restricting accessibility, challenges in training healthcare professionals on the use of advanced blood management tools, concerns over the reliability and accuracy of certain systems, and regulatory hurdles delaying the approval and market entry of innovative solutions are the major challenges faced by the United States Blood Management System Market in the upcoming years.

Rising demand for efficient blood management solutions in healthcare settings, increasing focus on improving patient outcomes through advanced blood transfusion technologies, growing emphasis on patient safety and regulatory compliance, advancements in blood storage and tracking technologies, and the increasing number of surgeries and trauma cases requiring precise blood management are the major drivers for the United States Blood Management System Market.

Related Reports

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.